TH
Thomas Edward Hamilton

Thomas Edward Hamilton insider trades: Larimar Therapeutics (LRMR) stock buys and sales

Larimar Therapeutics Last trade Jul 6, 2026 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$667K
Bought, last 12 months
2 buys
10
Open-market trades
since 2019
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 6, 2026LRMR↑ Buy$167K
Feb 27, 2026LRMR↑ Buy$500K
Feb 16, 2024LRMR↑ Buy$500K
Sep 16, 2022LRMR↑ Buy$1000K
Jun 30, 2021LRMR↑ Buy$496K
May 3, 2021NLY↓ Sell$734K
May 15, 2020NLY↑ Buy$1.2M
May 17, 2019NLY↑ Buy$284K
May 17, 2019NLY↑ Buy$284K
May 17, 2019NLY↑ Buy$284K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LRMR insiders

Open-market trades in the last 12 months

About Thomas Edward Hamilton's insider trades

Thomas Edward Hamilton is an insider at Larimar Therapeutics (LRMR). Since May 17, 2019, Thomas has reported 9 open-market purchases worth $4.7M and 1 sale worth $734K on SEC Form 4. In the last 12 months: 2 buys ($667K).

Their filings also include grants and awards (15 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LRMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.